Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 16, 2026

6 Words From Now-Former Fed Chair Jerome Powell That Will Echo Through Wall Street for Years to Come

View original at finance.yahoo.com
6 Words From Now-Former Fed Chair Jerome Powell That Will Echo Through Wall Street for Years to Come You might not realize it, but you've just borne witness to history…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Trump vocally criticized Powell and FOMC members for not aggressively cutting interest rates to 1% or lower.

    60% confidence
  • Elevated inflation caused by President Trump's tariffs and/or the Iran war meant the FOMC was not in a position to cut rates further.

    60% confidence
  • Powell offered rare commentary on equity valuations in September, an atypical act for a sitting Fed chair whose mandate is price stability and maximum employment — not stock market guidance.

    60% confidence
  • Stock market valuations were experiencing irrational exuberance driven by the rapid rise and proliferation of the internet, creating a speculative dynamic in equity prices.

    60% confidence

Data points we hold from this source

Federal Reserve · employee count17 chairs_historically
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
6 Words From Now-Former Fed Chair Jerome Powell That Will Echo Through Wall Street for Years to Come — Source | Via News | ViaNews Market